USPTO serial 79283146
SUMITOVANT BIOPHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 23, 2021
- Examiner
- ELTON, DAVID JONATHAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SUMITOVANT BIOPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey Costellia
Jeffrey Costellia NIXON PEABODY LLP799 9th Street NW, Suite 500WASHINGTON, DC 20001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterological system, and ophthalmologic system; pharmaceutical preparations for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparation for use in chemotherapy; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the urogenital system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the dermatologic system; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for hereditary diseases; pharmaceutical diagnostic preparations for medical purposes; pharmaceutical diagnostic reagents for medical use; biologic preparations for medical and therapeutic purposes, namely, vaccines; biologic preparations for medical and therapeutic purposes, namely, cells for medical or clinical use; biologic preparations for medical and therapeutic purposes, namely, nucleic acid sequences for medical purposes | ACTIVE | — |
| 009 | Calculating machines; data processing apparatus; computers; computer hardware; computer peripherals; Downloadable computer software for providing, analyzing and generating reports; downloadable computer software and programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable computer software and programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest; downloadable computer software for accessing, controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuring, monitoring, processing and tracking health, wellness and medical information; downloadable computer software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; downloadable computer software for analytics in the fields of public health, healthcare, biomedical research; downloadable computer software for analytics for clinical trial data | ACTIVE | — |
| 035 | Advertising; publicity agency services; business management; business management assistance; business administration; business consulting services; secretarial services; providing office functions; business research; providing business information; marketing research; market analysis services; provision of market research information; marketing services; compiling of information into computer databases; updating and maintenance of data in computer databases; business data analysis; assistance, advisory services and consultancy with regard to business analysis, in the field of healthcare, biomedical and pharmaceutical research and pharmaceutical preparations; statistical analysis; statistical analysis and reporting in the field of healthcare, biomedical and pharmaceutical research and pharmaceutical preparations; statistical analysis and reporting services for business purposes in the fields of healthcare data, biomedical and pharmaceutical research and clinical trial data; business analysis in the field of healthcare, biomedical and pharmaceutical research and pharmaceutical preparations; systematization of data in computer databases | ACTIVE | — |
| 042 | technical consultancy relating to technical and scientific analysis in the fields of healthcare, biomedical and pharmaceutical research and pharmaceutical preparations; medical research; chemistry services, namely, research in the field of chemistry; clinical trials, namely, conducting clinical trials for others; analysis of technical data, namely, data analytics in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; testing, inspection or scientific research of pharmaceuticals, cosmetics or foodstuffs; providing medical and scientific research information relating to clinical trials of pharmaceuticals; medical and scientific research in the field of pharmaceutical and biologic therapeutic products; providing information relating to testing, inspection or medical and scientific research of pharmaceuticals; cloud computing featuring software for use in database management in the field of healthcare, pharmaceuticals, biomedicine, clinical trial, post-market trial data; provision of scientific and technological information and data relating to scientific and technological research and development in the fields of healthcare, biomedical and pharmaceutical research and pharmaceutical preparations; rental of computers; providing temporary use of online non-downloadable computer programs on data networks containing databases of pharmaceutical products, medical information, clinical trial data as well as data from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; software as a service [SaaS] featuring software for providing information online in the fields of biomedical research and clinical trials from a computer database or the Internet; computer software design, computer programming, and maintenance of computer software | ACTIVE | — |
| 044 | Provision of medical information; providing health information; providing medical information from a web site; providing healthcare information from a web site; health counseling; provision of medical information relating to pharmaceutical and biologic therapeutic products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sumitomo Dainippon Pharma Co., Ltd.
- Other trademarks owned by Sumitomo Dainippon Pharma Co., Ltd.
- Other trademarks owned by Sumitomo Pharma Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SUMITOVANT BIOPHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 30, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 10, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 10, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 23, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 5, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 18, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 18, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 18, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 30, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 30, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 30, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 30, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 30, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 13, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 13, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 10, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 10, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 10, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 3, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 3, 2021 | ALIE | ASSIGNED TO LIE | — |
| Oct 27, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 8, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jul 1, 2020 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Jun 26, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| May 15, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 28, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 28, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 17, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 15, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 13, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |